September 27, 2023
This lung cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
September 27, 2023
This gastric cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
May 8, 2023
This liver cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.
July 1, 2022
Kidney Cancer Tumor Microarrays derived from PDX for H&E and IHC staining, formalin-fixed and embedded in paraffin.
July 1, 2022
Lung Cancer Tumor Microarrays derived from PDX for H&E and IHC staining, formalin-fixed and embedded in paraffin.
July 1, 2022
Cervical Cancer Tumor Microarrays derived from PDX for H&E and IHC staining, formalin-fixed and embedded in paraffin.
July 1, 2022
Bladder Cancer Tumor Microarrays derived from PDX for H&E and IHC staining, formalin-fixed and embedded in paraffin.
July 1, 2022
Breast Cancer Tumor Microarrays derived from PDX for H&E and IHC staining, formalin-fixed and embedded in paraffin.
April 13, 2022
Breast Cancer Tumor Microarrays derived from PDX for H&E and IHC staining, formalin-fixed and embedded in paraffin.
April 13, 2022
This colorectal cancer tumor microarray is derived from patient derived xenograft (PDX) tumor samples. Each tumor sample is formalin fixed, paraffin embedded, and spotted in triplicate on the TMA.